Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
Preprint
- 11 February 2020
- preprint
- Published by Cold Spring Harbor Laboratory in medRxiv
Abstract
Our manuscript was based on surveillance cases of COVID-19 identified before January 26, 2020. As of February 20, 2020, the total number of confirmed cases in mainland China has reached 18 times of the number in our manuscript. While the methods and the main conclusions in our original analyses remain solid, we decided to withdraw this preprint for the time being, and will replace it with a more up-to-date version shortly. Should you have any comments or suggestions, please feel free to contact the corresponding author.Keywords
This publication has 18 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Recent advances in the detection of respiratory virus infection in humansJournal of Medical Virology, 2020
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoVNature Communications, 2020
- Comparing nonpharmaceutical interventions for containing emerging epidemicsProceedings of the National Academy of Sciences, 2017
- A New Framework and Software to Estimate Time-Varying Reproduction Numbers During EpidemicsAmerican Journal of Epidemiology, 2013
- The Transmissibility and Control of Pandemic Influenza A (H1N1) VirusScience, 2009
- Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact GroupsJournal of the Royal Statistical Society Series C: Applied Statistics, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- The Statistical Analysis of Failure Time DataJournal of the American Statistical Association, 2003
- Clinical presentations and outcome of severe acute respiratory syndrome in childrenThe Lancet, 2003